Urinary matrix metalloproteinase-9 and interleukin-6 and renal manifestations of primary Sjögren's syndrome [2]

Rheumatology

Volumn 43, Issue 6, 2004, Pages 807-808

  Pertovaara, Marja ^a   Hulkkonen, J ^b   Hurme, M ^a,b   Lehtimaki T ^a,b   Pasternack, A ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; AMMONIUM CHLORIDE; CREATININE; GELATINASE B; IMMUNOGLOBULIN G; INTERLEUKIN 6;

ADULT; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE ACIDOSIS; LETTER; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SJOEGREN SYNDROME;

ADULT; AGED; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; SJOGREN'S SYNDROME;

EID: 3042526289     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh160     Document Type: Letter

References (9)

1. Pertovaara M, Korpela M, Kouri T, Pasternack A. The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients. Rheumatology 1999;38:1113-20.
2. Konttinen YT, Halinen S, Hanemaaijer R et al. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol 1998;17:335-47.
3. Hanemaaijer R, Visser H, Konttinen YT, Koolwijk P, Verheijen JH. A novel and simple immunocapture assay for determinations of gelatinase (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels. Matrix Biol 1998;17:657-65.
4. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 2001;42:2283-92.
5. Perez P, Goicovich E, Alliende C et al. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2000;43: 2807-17.
6. Kossakowska AE, Edwards DR, Prusinkiewicz C et al. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 1999;94:2080-9.
7. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of IL-6 gene in primary Sjögren's syndrome (pSS) and correlate with clinical manifestations of the disease. Rheumatology 2001;40:656-61.
8. Grisius MM, Bermudez DK, Fox PC. Salivary and serum interleukin 6 in primary Sjögren's syndrome. J Rheumatol 1997;24: 1089-91.
9. Tishler M, Yaron I, Geyer O, Shirazi I, Naftaliev E, Yaron M. Elevated tear interleukin-6 levels in patients with Sjögren's syndrome. Ophthalmology 1998;105:2327-9.